Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cooper

Showing results (841-850 of 855) with videos related to

Pageof 86
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 3, 2010
Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 proteaseXianfeng Li, Yong-Kang Zhang, Yang Liu, et al.
Hospital Pediatrics|July 8, 2026
The Crisis of Adolescent Firearm Reinjury: A 14-Year Retrospective Cohort AnalysisKristen L Mueller, Daphne Lew, Nicholas Szoko, et al.
The British Journal of Dermatology|June 3, 2009
How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase TwoC Flohr, G Weinmayr, S K Weiland, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2012
Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groupsXianfeng Li, Yang Liu, Yong-Kang Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moietiesXianfeng Li, Suoming Zhang, Yong-Kang Zhang, et al.
Journal of Medicinal Chemistry|June 8, 2000
Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structuresD R Bolin, A L Swain, R Sarabu, et al.
Cell|September 30, 2004
Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null miceJiandie Lin, Pei-Hsuan Wu, Paul T Tarr, et al.
Leukemia & Lymphoma|March 20, 2023
Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemiaRyan D Cassaday, Lucas C Zarling, Kelsey-Leigh A Garcia, et al.
Neurology|January 21, 2009
Incidence of acquired demyelination of the CNS in Canadian childrenB Banwell, J Kennedy, D Sadovnick, et al.
Annals of Internal Medicine|July 14, 2025
Evaluation of a Region-Wide Hospital-Based Violence Intervention Program : A Pilot Cohort StudyKristen L Mueller, Taylor M Kaser, Benjamin P Cooper, et al.
Pageof 86

Showing results (841-850 of 855) with videos related to

Sort By:
Pageof 86
Bioorganic & Medicinal Chemistry Letters|November 3, 2010
Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 proteaseXianfeng Li, Yong-Kang Zhang, Yang Liu, et al.
Hospital Pediatrics|July 8, 2026
The Crisis of Adolescent Firearm Reinjury: A 14-Year Retrospective Cohort AnalysisKristen L Mueller, Daphne Lew, Nicholas Szoko, et al.
The British Journal of Dermatology|June 3, 2009
How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase TwoC Flohr, G Weinmayr, S K Weiland, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2012
Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groupsXianfeng Li, Yang Liu, Yong-Kang Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moietiesXianfeng Li, Suoming Zhang, Yong-Kang Zhang, et al.
Journal of Medicinal Chemistry|June 8, 2000
Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structuresD R Bolin, A L Swain, R Sarabu, et al.
Cell|September 30, 2004
Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null miceJiandie Lin, Pei-Hsuan Wu, Paul T Tarr, et al.
Leukemia & Lymphoma|March 20, 2023
Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemiaRyan D Cassaday, Lucas C Zarling, Kelsey-Leigh A Garcia, et al.
Neurology|January 21, 2009
Incidence of acquired demyelination of the CNS in Canadian childrenB Banwell, J Kennedy, D Sadovnick, et al.
Annals of Internal Medicine|July 14, 2025
Evaluation of a Region-Wide Hospital-Based Violence Intervention Program : A Pilot Cohort StudyKristen L Mueller, Taylor M Kaser, Benjamin P Cooper, et al.
Pageof 86